io9 is an AI-driven digital pathology company that will help transform the current cumbersome and expensive companion diagnostic therapeutic selection process for oncology patients. io9’s StargateTM software utilizes a digital image of routine pathology slides to identify well defined biomarkers such as Homologous Recombination Deficiency (HRD) and KRAS faster, cheaper and more accurately than traditional molecular testing. In today’s environment, oncologist and their patients can wait weeks for molecular results that dictate potential lifesaving therapies. StargateTM has the potential to change this process by determining the critical biomarkers utilizing cutting edge AI software developed at the Moores Cancer Center at the University of California San Diego. The ability to accurately determine the relevant biomarkers from the pathology slides will allow oncologist to prescribe appropriate therapies sooner providing a greater chance for their patient’s successful treatment.